
Home » Jazz and Azur merge to form Jazz Pharmaceuticals
Jazz and Azur merge to form Jazz Pharmaceuticals
January 20, 2012
Jazz Pharmaceuticals and Azur Pharma have completed their business combination, creating Jazz Pharmaceuticals plc, a specialty biopharmaceutical company based in Dublin, Ireland.
"As Jazz Pharmaceuticals plc, we are a growing, profitable specialty biopharmaceutical company with a diverse portfolio of products in the central nervous system and women's health areas," said Bruce Cozadd, chairman and CEO at Jazz Pharmaceuticals. "We now have a strengthened management team, a broader commercial organization and an efficient platform for further growth, with resources to build our product portfolio and a future pipeline."
Jazz Pharmaceuticals has approximately 430 employees, including a commercial organization focused around four key areas: narcolepsy, severe chronic pain, psychiatry and a diversified portfolio of women's health products. In addition to its headquarters in Dublin, Ireland, the company has offices in Palo Alto, Calif., and Philadelphia, Penn.
Upcoming Events
-
25Apr
-
26Apr
-
27Apr
-
17May
-
21May